Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × 1-dodecylpyridoxal × Clear all

NCT05201001 2023-09-11

APX005M

Phase 2 Withdrawn

Ovarian Neoplasms

NCT04887961 2021-08-09

MITO36

Phase 2 Unknown

Ovarian Neoplasms

NCT01991210 2017-08-21

A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC)

Phase 2 Terminated

Ovarian Neoplasms